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Abstract: In traditional communities of the Brazilian Amazon, the copaiba oleoresin (C. reticulata 
Ducke) is widely known for its therapeutic activity, especially its wound healing and anti-
inflammatory actions. Our study aimed to evaluate these effects in oral lesions and the safety of the 
dosage proposed. A punch biopsy wound was induced on the ventral surface of the tongue of forty-
five male Wistar rats under anesthesia. Animals were randomly allocated to one of three groups 
based on the treatment: control, corticoid and copaiba. A daily dose of each treatment and vehicle 
was administrated by oral gavage for three consecutive days. Sample collections took place on the 
third, seventh and 15th days post-wounding for clinical and histopathological analyses. Blood was 
collected on the third and seventh days for kidneys and liver function tests. Semi-quantitative 
analyses were performed based on scores of inflammation and reepithelization. Tissue collagen 
deposition was detected by PicroSirius red staining. Copaiba-treated wounds revealed a smaller 
wound area, decreased of acute inflammatory reaction and enhanced reepithelization. The levels of 
kidney and liver function tests did not reveal presence of damage post-treatments. Our findings 
suggest that copaiba oleoresin is a safe and effective alternative therapy for inflammation and tissue 
repair of oral wounds in this animal model.  
Keywords: copaiba oleoresin; wound healing; alternative therapy; natural anti-inflammatory; C. 
reticulata Ducke 
 
1. Introduction 
Aphthae and traumatic ulcers are common inflammatory conditions in the oral mucosa. These 
oral lesions are painful and produce discomfort during food intake or even speaking, interfering with 
the patient’s quality of life [1,2]. Although there is no a standard treatment, management is based on 
widely used anti-inflammatory therapy—such as corticoids—generally prescribed by dental 
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consultant [3,4]. However, corticoids therapy has been associated with a delay in the reepithelization 
of open wounds and high doses and long-term therapy with renal and liver damages [5,6]. Therefore, 
it is important to introduce alternative therapies in oral lesions.  
The use of medicinal plants for healing is the oldest form of medicinal practice of mankind [7]. 
Contemporary science has shown that some natural compounds have high anti-inflammatory, 
antioxidant and regenerative effects [8]. Brazil has great biodiversity (15%–20% of the world’s 
biodiversity), with about 60,000 varieties of plants, including some known for traditional use and 
others still not explored [9]. Although the main advantages of using remedies of plant origin are the 
low cost and usually smaller number of side effects [10], they are composed of several substances in 
addition to the active compound which can have synergistic or antagonistic action [11]. Thus, it is 
important to study its effectiveness as well as its safety in medical applications. 
Traditional communities in the Brazilian Amazon have reported the anti-inflammatory, 
analgesic, and wound healing effects of copaiba oleoresin [12]. Copaiba oleoresin is extracted from 
the trunk of the genus copaifera tree, which is the most commonly used C. reticulata Ducke species. 
This oleoresin has resinous acids and volatile compounds in its chemical composition, such as 
diterpenes and sesquiterpenes. The predominant forms are β-Caryophyllene (bactericidal and anti-
inflammatory), β-Bisabolene (anti-inflammatory) and α-Humulene (anti-inflammatory)—present in 
several essential oils [13,14]. β-Caryophyllene is a ligand of the cannabinoid receptor 2 (CB2); its 
activation has been associated with decreasing pain, a major signal of inflammatory response, and 
enhancing reepithelization [15,16]. The α-Humulene has been related with the promotion of 
angiogenesis, helpful in wound healing [17].  
Previous studies revealed the effectiveness of copaiba oleoresin in modulating inflammatory 
infiltrate in oral lesions compared to corticoid-treated [14,18]. However, the effect on reepithelization 
and the safety of the dosage administrated concerning renal and liver functions, have not been 
assessed. Thus, this study aimed to investigate the therapeutic effects of copaiba oleoresin (C. 
reticulata Ducke) on reepithelization by decreasing inflammatory response in an animal model of 
traumatic ulcer induced in the tongue of rats. In addition, we sought to analyze the safety of the 
dosage used in this experiment through analyses of biochemical parameters of liver and kidneys 
functions in order to introduce the oleoresin as an alternative therapy in oral lesions. 
2. Results 
2.1. Copaiba Oleoresin Accelerates the Wound Contraction 
The clinical analysis demonstrated that copaiba oleoresin promoted an early reduction of the 
wound area when compared to corticoid and control (Figure 1). The wound area on day 3 (D3) post-
wounding showed significant difference between groups, in which the copaiba-treated wounds 
presented a significantly smaller area compared to the corticoid-treated group (p < 0.05) and controls 
(p < 0.01) (Figure 1A). On day 7 (D7), wounds had completely disappeared in the copaiba-treated 
group. Animals from all groups presented complete wound closure (area = 0 mm2) on day 15 (D15).  
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Figure 1. Clinical analysis of the wound area post-wounding. (A) Wounds post-treatment with 
copaiba oleoresin (200 mg/kg/day) and corticoid–dexamethasone (0.5 mg/kg/day), and untreated 
wounds. Copaiba-treated ulcers presented smaller wound area on D3 and completely disappeared in 
D7. Corticoid treatment promoted a reduction of the wound area on D3 compared to controls, but 
less effective than the copaiba-treated group. (B) Graph comparing the contraction of the wounds 
throughout the time at D3 (n = 15), D7 (n = 15) and D15 (n = 15) in untreated and treated groups. Two-
way analysis of variance (ANOVA) followed by Tukey’s multiple comparison tests (* p < 0.05). 
2.2. Copaiba Oleoresin Modulates Inflammatory Process and Accelerates Reepithelization  
The semi-quantitative analysis revealed significant differences in inflammatory and 
reepithelization scores between groups on D3 (* p < 0.05) (Figure 2B) and no significant differences 
on D7 (Figure 3B). Copaiba-treated wounds presented significant higher scores (more advanced 
inflammatory stage which indicates decreased acute inflammatory reaction) on D3 (Figure 2B) and 
higher reepithelization scores (more advanced stage of tissue repair) on D3 and D7 compared to other 
groups (* p < 0.05) (Figures 2C and 3C). 
Although all the groups presented open wounds on D3, differences in connective tissue were 
observed among the groups. Copaiba-treated wounds presented recruitment of inflammatory cells 
such as predominance of granulation tissue (lymphocytes, macrophages, collagen and new vessels) 
in most of the samples analyzed (Figure 2A,B). Therefore, higher reepithelization scores were 
observed at an early time point when compared to corticoid-treated and control groups (Figure 2c). 
Acute inflammatory cells (neutrophils) predominated in most wounds from the corticoid and control 
group on this day (Figure 2A). 
Int. J. Mol. Sci. 2020, 21, 3568 4 of 14 
 
 
Figure 2. Histopathological analysis of treated and untreated wounds at D3. (A) Five-μm sections 
stained by hematoxylin and eosin (HE) showing copaiba-treated wounds with predominance of 
granulation tissue, whereas acute inflammatory cells (neutrophils) predominated in most wounds 
from the corticoid and control groups. (B) Copaiba-treated wounds presented a significantly higher 
score of the inflammatory stage, which indicates a decreased acute inflammatory reaction and (C) a 
more advanced stage of reepithelization. The corticoid-treated wounds showed lower scores of 
reepithelization at D3, demonstrating poor tissue repair (original magnification ×200 and ×1000). One-
way ANOVA and Tukey’s post hoc tests (n = 15) (* p < 0.05).  
 
Figure 3. Histopathological analysis of treated and untreated wounds at D7. (A) Five-μm sections 
stained by HE, showing complete closure of the wound with a uniform thickness in most of the 
copaiba-treated samples analyzed compared to the corticoid-treated and control samples. (B) 
Inflammatory scores presented no significant differences between groups on this day. (C) Copaiba-
treated wounds presented an advanced reepithelization stage. The corticoid-treated group still 
revealed a poor reepithelization performance on this day (original magnification x200 and x1000). 
One-way ANOVA and Tukey’s post hoc tests (n = 15) (* p < 0.05).  
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The resolution of the inflammatory stage in the connective tissue characterized by the 
disappearance of chronic inflammation was observed in all the groups on D7 (Figure 3A), though 
with some differences in collagen deposition. 
2.3. Copaiba Oleoresin Promoted Collagen Formation 
In the PicroSirius red staining on D3, the control and corticoid-treated groups revealed areas 
with no red or green birefringence, indicating the absence of collagen fibers and part of the wound 
with thin, delicate, loosely arranged collagen fibers (+1 score). Copaiba-treated wounds revealed thin, 
delicate, loosely arranged collagen fibers in some areas and thicker and gross fibers in other areas of 
the wound in most samples analyzed (+2 score) (Figure 4). The collagen was significantly better 
organized in the copaiba-treated than in corticoid and control groups (** p < 0.01) (Figure 4A).  
 
Figure 4. Photomicrographs of PicroSirius red staining. (A) Corticoid-treated and controls’ wound 
area showed a black area (especially on the surface), indicating the absence or a small number of 
collagen fibers. On the side and bottom of the wound, poorly organized thin collagen fibers were 
observed. Copaiba-treated wounds were filled with more organized collagen fibers. (PSR, original 
magnification, × 100 and × 400). (B) Graphs of collagen content analysis on D3 (n = 15) and (C) D7 (n 
= 15). Note that on D3 and D7, corticoid-treated and control groups showed less organized fibers than 
the copaiba-treated group (original magnification ×100 and ×400). One-way ANOVA followed by 
Tukey’s multiple comparison tests (* p < 0.05, ** p < 0.01). 
On D7, corticoid-treated and control wounds displayed thin collagen fibers, which were poorly 
organized. In the groups treated with copaiba, some denser collagen fibers with a thicker appearance 
were noted in the wound. These fibers were more parallel to the epithelium and demonstrated a more 
organized pattern in comparison to the control (* p < 0.05) and corticoid group (** p < 0.01). (Figure 
4C) 
Int. J. Mol. Sci. 2020, 21, 3568 6 of 14 
 
2.4. The Dosage of Copaiba Administered Concluded to Be Safe for Liver and Kidneys 
The levels of biochemical parameters of renal and liver functions are commonly increased in 
blood plasma due to the presence of different diseases or as a signal of damage to the liver or kidneys 
[5,19,20]. In this regard, the serum levels of urea (Figure 5A) and creatinine (Figure 5B) did not reveal 
significant differences between copaiba-treated animals and the other groups after the dosage 
administrated by oral gavage for three consecutive days. 
 
Figure 5. Levels of renal function parameters in different groups. (A) No significant differences 
between the groups were found in the levels of urea and (B) creatinine in plasma at D3 (n = 15) and 
D7 (n = 15), suggesting that the dosage of both copaiba and corticoid administered was harmless for 
the kidneys. The results are expressed as the mean ± standard error of the mean. One-way ANOVA 
and Tukey’s post hoc tests. 
The serum levels of alanine aminotransferase (ALT) were significantly decreased in copaiba and 
corticoid-treated at the D7 and there were no differences between the groups at the D3 (Figure 6A). 
No significant differences were found in aspartate aminotransferase (AST) values between the groups 
(Figure 6B). The direct bilirubin (DB) values were significantly increased in the corticoid-treated 
compared to the copaiba-treated and control groups (Figure 6C). No significant differences were 
found in the serum levels of gamma-glutamyl transferase (GGT) between the groups (Figure 6D).  
 
Figure 6. Comparative biochemical parameters levels of liver function in different groups: (A) ALT, 
(B) AST, (C) DB and (D) GGT (* p < 0.05). Although DB was elevated in the corticoid-treated group 
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on D3 (n = 15) and D7 (n = 15) (Figure 6C), GGT levels presented normal levels in all the groups. The 
results are expressed as the mean ± standard error of the mean. One-way ANOVA and Tukey’s post 
hoc tests (* p < 0.05). 
3. Discussion 
Despite oral mucosa wounds being able to heal more rapidly than skin wounds [21], some oral 
lesions may produce discomfort during food intake or even speaking, interfering with the patient’s 
quality of life, making effective wound healing therapy necessary [1,2]. The results of this animal 
model study demonstrate the safety and effectiveness of copaiba oleoresin (C. reticulata Ducke) on 
the wound-healing process in oral mucosa compared to corticoid therapy—often prescribed by 
dental professionals for oral lesions [3,4]. The systemic administration of the oleoresin promoted an 
anti-inflammatory effect at an early time point, accelerating the wound resolution when compared to 
untreated and corticoid-treated wounds, in which a poor tissue repair was observed. Moreover, the 
biochemical analyses revealed that the dosage of Copaiba oleoresin administered in our experiment 
was harmless to the kidneys and liver of Wistar rats. 
Wound healing occurs in three overlapping phases: inflammatory, proliferative and remodeling 
[22], although it is more accelerated in oral mucosa wounds than cutaneous wounds [21]. In either 
case, the inflammatory reaction is the earliest event to take place through neutrophils and 
macrophages infiltrations and proliferation promotion [23]. Although our clinical analysis showed a 
reduction of wound area in corticoid-treated on the third day post-wounding (Figure 1A), the 
connective tissue still demonstrated the predominance of acute inflammatory cells (neutrophils) in 
most wounds from the corticoid-treated as well as untreated groups, whereas in the copaiba-treated 
group, an advance inflammatory stage with less neutrophils and the predominance of granulation 
tissue such as macrophages, lymphocytes, collagen and new vessels were observed, suggesting an 
accelerated tissue repair (Figure 2A). It has been determined that macrophages play an important 
role in the acceleration of tissue repair [23]. Apparently, the corticoid promoted an anti-inflammatory 
effect on the first days post-wounding; nonetheless, the poor wound healing performance observed 
from the third day onwards suggests an adverse effect delaying reepithelization (Figure 2C, 3C and 
5). These results agree with previous studies in which it was reported that corticoid therapy might 
delay reepithelization by inhibiting the growth of new vessels (angiogenesis), although the 
mechanism through which this inhibition occurs has not been stablished [24]. 
The wound healing activity of the copaiba oleoresin can be mainly attributed to the anti-
inflammatory activity of the β-Caryophyllene—since it is commonly the predominant compound 
found in oleoresins from the copaifera species [13] but also to the synergetic activity of the β-
Caryophyllene with the α-Humulene [25]—a compound found in the C. reticulata Ducke [13]. β-
Caryophyllene is a ligand of the cannabinoid receptor 2 (CB2) presented in various essential oils and 
its activation has been associated with decreasing pain, a major signal for inflammatory response, 
and enhancing reepithelization through multiple routes [16]. The CB2 receptors are involved in 
stimulating the secretion of pro-inflammatory cytokines and increasing T and B lymphocyte 
response. Cells treated in vitro with β-Caryophyllene have shown a reduction in the inflammatory 
phase and an early activation of the proliferative phase [13–15]. This proliferative phase consists of 
four fundamental tissue modifications: reepithelization, formation of new vessels, granulation tissue 
formation and collagen deposition [16]. The α-Humulene has been involved in the secretion of 
Interleukin 8 (IL-8), a chemokine produced by macrophages, which has various functions, including 
promoting the formation of new vessels [17]. In one study, the β-Caryophyllene was synergistic with 
α-Humulene, potentiating the secretion of IL-8 [25], being helpful in the proliferative phase. At the 
beginning of this phase, the collagen fibers present a disorganized pattern; subsequently, new fibers 
are produced and deposited in a more organized way following the adjacent connective tissue, 
initiating the remodeling phase [23,26]. Concerning this, our results revealed that oleoresin might 
accelerate the remodeling phase since the collagen was significantly better organized in copaiba-
treated groups than in the corticoid-treated and control groups, in which less organized fibers were 
observed (Figure 4). Furthermore, the histological analyses also show an advanced reepithelization 
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in the copaiba-treated group with a complete closure of the wound with a uniform thickness in most 
samples analyzed on the seventh day. In contrast the corticoid-treated group presented an open 
wound with a new oral mucosa lining at the wound edges with an irregular thickness, even worse 
than the untreated, in which reepithelization covering the entire wound was observed, though with 
irregular thickness (Figure 3A). 
In a previous study of our group [18], the anti-inflammatory effect of systemic administration of 
copaiba oleoresin (C. reticulata Ducke) was assessed in transfixing injuries of tongues in Wistar rats 
and also revealed a modulation of the inflammatory response, similarly to the present study. 
However, the enhancement of reepithelization by this modulation was not evaluated because the 
wounds crossed the muscular plane and the wound resolution could not be observed at the end of 
the experiment [18]. Another study showed that 200 and 400 mg/kg body weight of copaiba oleoresin 
reduced neutrophilic infiltration and colonic mucosal damage following acetic-acid-induced colitis 
in rats [27]. The same attenuation of neutrophil recruitment was found following acute damage to 
the central nerve system, in which the oleoresin acted as an anti-inflammatory and neuroprotective 
agent [28]. Nonetheless, when oleoresin effectiveness was evaluated by topical application in oral 
lesions, it failed to accelerate wound healing [14]. Therefore, it may be suggested that copaiba 
oleoresin is only effective by systemic administration in wound healing therapy, probably due to the 
better absorption of its volatile compounds. 
A recent study demonstrated that the oral cavity itself is primed for wound repair. Priming 
allows to rapidly control and limit inflammatory responses, leading to a faster wound closure 
compared to cutaneous wound healing. The gene expression signature changes during oral mucosal 
were analyzed in that study to identify and explain the mechanisms that define accelerated oral 
wound healing and it presented evidence that transcriptional regulators that define oral 
keratinocytes, such as SOX2 (sex-determining region Y-box 2) and PITX1 (paired-like homeodomain 
1), hold the key to the activation of the molecular events responsible for accelerated wound resolution 
in oral healing [21]. These findings open a gap for future studies to identify the specific pathways 
activated by the copaiba oleoresin and their potential to accelerates wound repair and tissue 
regeneration in oral mucosa and furthermore, to understand the mechanism through which 
corticoids delay reepithelization. 
Concerning the dosage of copaiba oleoresin, it is possible to indicate a safety margin for its oral 
administration as a therapeutic agent, since the LD50 was estimated to be greater than 2000mg/kg 
body weight and classified as category 5, according to the Globally Harmonized System for the 
Classification and Labeling of Chemicals (GHS) [29]. However, all substances can cause harm at a 
certain level and it has been reported that taking high doses of copaiba can cause symptoms of 
intolerance, nausea, vomiting, colic and diarrhea, and prolonged use may cause renal and liver 
damages [29]. On the other side, although low doses of corticoids are considered safe, high doses of 
corticoid therapy have been also associated with renal and liver damages [6,30]. Therefore, a standard 
dosage of dexamethasone considered safe for the liver and kidneys was administered in this 
experiment (Table 1) [5,30]. In this regard, the dosage of copaiba oleoresin and corticoid used in our 
study was concluded to be in safe for the kidneys, since our biochemical analyses show normal levels 
of creatinine and urea in the plasma of all animals (Figure 5A,B). When assessing liver damage, our 
results show that the levels of ALT in the plasma of both copaiba and corticoid-treated were normal 
on the third day and decreased on the seventh day (Figure 6A). However, the values of conjugated 
bilirubin were significantly increased in the corticoid-treated on the third and seventh days (Figure 
6C). Despite the elevated values of DB in the corticoid-treated group, the levels of GGT in plasma 
show normal values in all the groups (Figure 6D). Therefore, the higher values of conjugated bilirubin 
in the blood of the corticoid-treated groups may indicate a temporary biliary obstruction but without 
a risk of permanent damage considering that a safe dosage of corticoid was used in this experiment. 
Moreover, the dosage of copaiba administered in this study showed no damage signals in liver nor 
kidneys in the biochemical assessment (Figures 5 and 6).  
Taken together, the aforementioned findings demonstrate that the dosage of copaiba oleoresin 
(C. reticulata Ducke) administered by oral gavage in our study were harmless to the liver and renal 
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functions, and is a more effective therapy for inflammation and tissue repair of oral wounds 
compared to corticoid therapy. Oleoresin modulated the inflammatory infiltrate and promoted a 
faster resolution and closure of the wound with higher levels of indexes of reepithelization and better 
organization of the collagen fibers’ deposition. Nonetheless, more studies are needed to identify the 
specific pathways activated by the copaiba oleoresin and their potential to accelerate wound repair 
and tissue regeneration in human oral mucosa in order to introduce it as an alternative therapy. 
4. Materials and Methods  
4.1. Study Design 
This study was a prospective, randomized, controlled and blinded animal model study based 
on the Guide for the Care and Use of Laboratory Animals and the Animal Research: Reporting of In 
Vivo Experiments (ARRIVE) guidelines [31]. 
4.2. Plant Material, Characterization and Acute Oral Toxicity Test 
The oleoresin was the same sample as that used in previous studies [18,28], collected and 
characterized by researchers from the Brazilian Agricultural Research Corporation (EMPRAPA). The 
extraction of the oleoresin was made by artificial exudation from the trunk of a native tree C. reticulata 
Ducke located in the municipality of Belterra, Pará, Brazil, approximately 30 years old. After 
collection, the oleoresin was stored in the absence of light, oxygen and heat in order to keep its volatile 
compounds stabilized. A sample of the plant was placed at the IAN EMBRAPA Herbarium 
(Exsiccate: 183,939). The characterization by gas chromatography–mass spectrometry (GC–MS) of the 
sample used was described by Santos-Guimarães et al., 2012 (Table A1). 
The dose of the oil administered was based on the acute oral toxicity test that was carried out in 
the previous study according to Guide 425/2008 of the Organization for Economic Cooperation and 
Development (OECD) [18]. The lethal dose that kills 50% of test animal population (LD50) was 
estimated using the limit dose test (2000 mg/kg body weight). An amount of 10% of the lowest dose 
that kills at least three animals was selected, i.e., 200 mg/kg body weight [18,29]. 
4.3. Animals and Experimental Protocol 
4.3.1. Animals 
Forty-five male Wistar rats (Rattus novegicus)—sample size based on test power from previous 
study [18]—with body weights of approximately 200–250g and 60 days old, were cared under aseptic 
conditions and housed individually in polypropylene cages in a climate-controlled room (12 h 
light/dark cycle and 25 ± 1°C) with food and water ad libitum. 
The experimental protocol was carried out with the rules issued by the National Council for 
Animal Control and Experimentation (CONCEA) and approved by the Ethics Committee on the Use 
of Animals (CEUA) of the Federal University of Pará (UFPA) under the license number 6534071217, 
on 01/18/2018. 
4.3.2. Experimental Groups and Wounding Method  
On the procedure day, animals were anesthetized by intraperitoneal injection of ketamine 
hydrochloride (90 mg/kg) and xylazine hydrochloride (10 mg / kg). After checking for loss of reflexes, 
animals were placed on the operating table in the supine position and with the oral cavity open. The 
tongue was pulled out with a clinical smooth press tack tweezer, exposing the ventral surface and 
was cleaned with 2% chlorhexidine before procedure. 
A traumatic ulcer was induced in the ventral surface 5 mm from the apex and at the midline 
with a standard technique using a disposable biopsy punch of circular format with a diameter of 
3mm. The punch was pressed into the tissue to penetrate to 2-mm deep without crossing the muscle 
plane. All wounds were induced by a single operator trained in a pilot study. 
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A random allocation into three groups was performed based on body weight and the type of 
treatment to be received was identified as one of the following: control, corticoid and copaiba (Table 
1). 
Table 1. Experimental groups according to the doses of treatment or vehicle received. 
Treatment Group (Sample Size) Doses Administered by Oral Gavage 
Control (n = 15) 200 mg/kg/day of saline solution and Tween 20 at 5% 
Corticoid (n = 15 0.5 mg/kg/day of Dexamethasone  
Copaiba (n = 15) 200 mg/kg/day of Copaiba oleoresin  
The copaiba oleoresin was mixed with saline, as an emulsion dilution, and Tween 20 at 5% to 
enable the solubilizing of the oil in saline. A daily dose of the treatments and vehicle was 
administered by oral gavage 12 h after induction of the traumatic ulcer and the next two days (D1 
and D2). A methodological summary of the experiment is shown in Figure 7. 
 
Figure 7. Methodological summary of the experiment (a) On day zero (D0), a traumatic ulcer in the 
ventral surface of tongue was induced with a standard punch biopsy technique (diameter 3mm). (b) 
Treatments were administrated 12 h post wounding, and the next two days by oral gavage. (c) On D3, 
D7 and D15, samples were collected for clinical, histopathological and histochemical analysis. Blood 
was collected by cardiac puncture for a biochemical assessment of liver and kidneys functions at D3 
and D7. (d) The different analyses were performed and (e) the data were tabulated for a comparative 
statistical analysis. The results are expressed as the mean ± standard error of the mean. 
In euthanasia days, five animals per group were anesthetized for sample collection. The blood 
was collected by cardiac puncture and transferred to heparinized tubes. Then, animals were 
euthanized by cervical dislocation for the dissection of the tongue. 
4.4. Clinical Analysis 
The animals were weighed on the surgery day (day 0) and euthanasia days (day N). Wounds 
were photographed next to a millimeter ruler. Wound area percentage was calculated by the 
following formula:  
Wound area (%) = [Area (day N)/Area (day 0)] × 100 (1) 
The wound area was calculated in pixels using ImageJ 1.48v software (National Institutes of 
Health, USA). Then, the values were converted to mm2 using the ruler as a scale reference. The clinical 
analysis was blinded. 
4.5. Histopathological ANALYSES 
After photographs were taken, the tongues were cut at their ends—to facilitate the penetration 
of the fixative—and immediately immersed in a 10% buffered formalin solution (10 mM phosphate 
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buffer, pH 7.4) for 72 h. The samples were dehydrated in an alcoholic battery (70%-100%), immersed 
in xylol solution for clarification and subsequently, were embedded in paraffin wax, cut into 5-μm 
sections and then stained with HE. Two experienced pathologists performed a blind semi-
quantitative evaluation based on scores.  
The inflammatory process was analyzed based on scores in which: Grade 1—acute inflammation 
(pyogenic membrane); Grade 2—predominance of diffuse acute inflammation; Grade 3—
predominance of chronic inflammatory process; Grade 4—resolution and healing (reduction or 
disappearance of chronic inflammation) [32]. Reepithelization was also evaluated based on scores in 
which: Grade 0—reepithelization at the end of the wound; Grade 1—reepithelization covering less 
than half the wound; Grade 2—reepithelization covering more than half of the wound; Grade 3—
reepithelization covering the entire wound with irregular thickness; Grade 4—reepithelization 
covering the entire wound and of normal thickness [33]. 
4.6. PicroSirius Red Staining 
Tissue sections (5μm) were stained with PicroSirius red staining and the analyzes were 
performed according to the intensity and pattern of the collagenization and the disposition of 
collagen fibers deposited at the wound site. The collagen fibers were classified into +1 (thin, delicate, 
loosely arranged collagen fibers seen throughout the wound area), +2 (thin, delicate, loosely arranged 
collagen fibers in some areas and thicker and gross fibers in other areas of the wound) and +3 (thick, 
gross, densely arranged collagen fibers seen throughout the wound area) [34]. The pattern of collagen 
arrangement of normal mucosa was used to define the score +3. 
The scores of the samples were defined in the polarized images by one pathologist and a 
descriptive analysis of each group was performed. A polarized microscope (Olympus BX51, Tokyo, 
Japan) coupled with a camera device (Olympus Q-color 5 RTV, Tokyo, Japan) and capture software 
(Q-capture, version 2.0.11) were used at ×100 and ×400 magnification to acquire the images. 
4.7. Analysis of Selected Biochemical Parameters of Liver and Kidney Functions 
Blood samples were centrifuged at 3000 rpm for 10 min and the plasma was collected and 
distributed in microtubules, and then stored in an ultrafreezer (−80 °C). The following plasma levels 
of liver function were assessed: ALT, AST, DB and GGT. The plasma levels of creatinine and urea 
were assessed to analyze renal function. All the tests were performed according to standard 
procedures facilitated by the manufacturer (Bioclin, Brazil). 
4.8. Statistical Analysis  
Statistical analyses were carried out using GraphPad Prism 6 (GraphPad Software, San Diego, 
California, USA). Clinical analyses were performed by a two-way analysis of variance (ANOVA). 
Histopathological and PSR analyses were performed by a one-way analysis of variance (ANOVA). 
All analyses were followed by Tukey’s multiple comparison test. The asterisks denote statistical 
significance (* p < 0.05; ** p ≤ 0.01; *** p ≤ 0.001; and not significant (NS) p ≥ 0.05). 
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Abbreviations 
MED Minimum Effective Dose 
CTG  Corticoid Group 
COG Copaiba Group 
CG Control Group 
D3 Day 3 
D7 Day 7 
D15 Day 15 
HE Hematoxylin and Eosin 
DL50 Median Lethal Dose 
GC-MS Gas Chromatography - Mass Spectrometry 
OECD Organization for Economic Cooperation and Develpment 
UFPA Federal University of Pará 
CEUA Ethics Committee on the Use of Animals 
ARRIVE Animal Research: Reporting of In Vivo Experiments 
CONCEA National Council for Animal Control and Experimentation 
ALT Alanine Aminotransferase 
AST Aspartate Aminotransferase 
CAPES Coordination for Improvement of Higher Education Personnel 
CNPq Brazilian National Council for Scientific and Technological Development 
EMBRAPA Brazilian Agricultural Research Corporation 
PROCAD National Academic Cooperation Program  
Appendix A 
Table A1. Chemical composition of the oleoresin volatiles of tree C. reticulata Ducke by GC-MS 
described by Santos-Guimarães et al. [28]. 
Constituents % 
δ-Elemene 0.2 
Cyclosativene 0.9 
α-Copaene 0.5 
β-Elemene 3.3 
β-Caryophyllene 37.6 
trans-α-Bergamotene 9.3 
Aromadendrene 0.9 
epi-β-Santalene 0.1 
α-Humulene + (E)-β-farnesene 5.3 
β-Chamigrene 0.9 
γ-Gurjunene 0.6 
γ-Curcumene 0.6 
β-Selinene 4.9 
α-Selinene 3.1 
(Z)-α-Bisabolene 1.8 
α-Bulnesene 2.1 
β-Bisabolene 13.9 
β-Curcumene 0.4 
β-Sesquiphellandrene 1.1 
(E)-γ-Bisabolene 1.3 
Caryophyllene oxide 0.2 
epi-β-Bisabolol 0.1 
β-Bisabolol 0.2 
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